Vol. 6, Issue 4, 2022October 16, 2022 CDT
Uses of CRISPR/Cas9 gene editing in chimeric antigen receptor T cell therapy to treat B-cell acute lymphoblastic leukemia
Uses of CRISPR/Cas9 gene editing in chimeric antigen receptor T cell therapy to treat B-cell acute lymphoblastic leukemia
Lill, Elena, and Jacob Odell. 2022. “Uses of CRISPR/Cas9 Gene Editing in Chimeric Antigen Receptor T Cell Therapy to Treat B-Cell Acute Lymphoblastic Leukemia.” Journal of High School Science 6 (4). https://doi.org/10.64336/001c.38886.